Evidence map›Paper›PMID 30021606›Full record

ArticleLipids in health and disease2018

Absorption rate of krill oil and fish oil in blood and brain of rats.

So Hyun Ahn, Su Jin Lim, Young Moo Ryu, Hye-Ryung Park, Hyung Joo Suh, Sung Hee Han

Open access · goldAbstract read
In one paragraph

Article in Lipids in health and disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 48 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Dietary LPC-BoundNutrients · 2024
    Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

So Hyun AhnDepartment of Food and Nutrition, Korea University, Seoul, 07249, Republic of Korea.
Su Jin LimAlpha B&H, Seoul, 06705, Republic of Korea.
Young Moo RyuAlpha B&H, Seoul, 06705, Republic of Korea.
Hye-Ryung ParkDepartment of Food Science and Biotechnology, Kyonggi University, Suwon, 16227, Republic of Korea.
Hyung Joo SuhBK21Plus, College of Health Science, Korea University, Seoul, 02841, Republic of Korea.
Sung Hee HanBK21Plus, College of Health Science, Korea University, Seoul, 02841, Republic of Korea. sungheeh3@gmail.com.ORCID http://orcid.org/0000-0003-0825-6687
Korea University · KRKyonggi University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundKrill (Euphausia superba) is a small marine crustacean with a lipid content. The mechanism of Krill oil function is not clear yet and research reports on the absorption rate of the phospholipids of krill oil in the blood and brain are very poor.

methodsWe studied the effect of oral short-term and long-term administration of Krill oils (KOs) on bioavailability in the blood and brain of rats. For short-term testing of fish and KO bioavailability, rats were divided into four groups: normal, fish oil (FO), Krill oil 1 (KO), and Krill oil 2 (CKO). The blood and brain were collected at 2, 4, 8, 12, 24, and 48 h after oral administration (1000 mg/rat). Five hundred milligrams of FO, KO, and CKO were orally administered daily for 2 weeks for long-term administration, and then the brain and blood were collected.

resultsTwo types of KOs showed high content of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) in the PL. The EPA content of CKO and KO were 41.13 and 32.49%, respectively. After short-term KO administration, KO showed a higher EPA content than CKO in the blood after 2 h. KO showed higher content of DHA than CKO even after 2 h. FO increased until 8 h, but then decreased rapidly until 12 h. Although the total unsaturated fatty acid (UFA) content of KOs was lower than the total UFS content in FO, the remaining UFS content in the brain was higher than that in FO over time. Following oral administration of FO, KO, and CKO for 1 and 2 weeks, triglycerides (TG) and PL contents in the blood for KOs were slightly higher than for FO. EPA and DHA levels in the brain were slightly higher in KOs following long-term administration, but the difference was not significant.

conclusionsBase on these findings, KOs have functional potential for the brain and vascular diseases, and can be utilized as a multi-functional material composed mainly of functional ingredients.

Indexed as

Administration, OralAnimalsBiological AvailabilityBlood-Brain BarrierBrainBrain ChemistryDietary Fats, UnsaturatedDocosahexaenoic AcidsEicosapentaenoic AcidEuphausiaceaFish OilsMalePhospholipidsRatsRats, Sprague-DawleyTriglyceridesDietary Fats, UnsaturatedDocosahexaenoic AcidsEicosapentaenoic AcidFish OilsPhospholipidsTriglyceridesBioavailabilityDocosahexaenoic acidEicosapentaenoic acidKrill oilPhospholipids

Identifiers

PMID30021606
PMCPMC6052518
OpenAlexW2884793907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.